Hoffmann-La Roche Ag, Hoffmann-La Roche Inc.
Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Family has litigation Priority claimed from CNPCT/CN2012/081190 external-priority Priority to CN201380046738.5A priority Critical patent/CN104603125A/en Priority to SG11201500377UA priority patent/SG11201500377UA/en Priority to EP13763201.4A priority patent/EP2892893B2/en Priority to ES13763201.4T priority patent/ES2617906T3/en Priority to CA2881322A priority patent/CA2881322A1/en Priority to KR1020157005893A priority patent/KR20150054795A/en Priority to BR112015004113A priority patent/BR112015004113A2/en Priority to JP2015530405A priority patent/JP6113285B2/en Priority to MA37942A priority patent/MA37942B1/en Application filed by F. Priority date (The priority date is an assumption and is not a legal conclusion. Hoffmann-La Roche Ag Hoffmann-La Roche Inc. Mayweg Zongxing Qiu Hong Shen Guozhi Tang Lisha Wang Guolong Wu Shixiang YAN Weixing Zhang Mingwei Zhou Wei Zhu Original Assignee F. Inventor Lei Guo Taishan HU Yimin Hu Buelent Kocer Xianfeng Lin Haixia Liu Alexander V. Google Patents WO2014037480A1 - 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection WO2014037480A1 - 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
0 kommentar(er)
